Neothetics, Inc. (NASDAQ:NEOT) released its quarterly earnings results on Wednesday. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, Bloomberg Earnings reports.

Shares of Neothetics (NASDAQ NEOT) traded up $0.05 during trading hours on Friday, reaching $1.25. The company had a trading volume of 260,916 shares, compared to its average volume of 4,240,000. Neothetics has a 1 year low of $0.30 and a 1 year high of $2.63.

TRADEMARK VIOLATION NOTICE: This article was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/11/10/neothetics-inc-neot-posts-quarterly-earnings-results.html.

Separately, ValuEngine upgraded Neothetics from a “strong sell” rating to a “sell” rating in a research note on Tuesday, October 17th.

About Neothetics

Neothetics, Inc is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

Earnings History for Neothetics (NASDAQ:NEOT)

Receive News & Stock Ratings for Neothetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neothetics Inc. and related stocks with our FREE daily email newsletter.